Innovid Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

BASIC AND DILUTED NET LOSS PER SHARE

BASIC AND DILUTED NET LOSS PER SHARE

3 Months Ended

Mar. 31, 2022

Basic and diluted net loss per share attributable to common stockholders was calculated as follows:


	Three months ended March 31,
	2022		2021
	(Unaudited)		(Unaudited)
Numerator:
Net loss	(7,449)		(1,936)
Accretion of preferred stock to redemption value	—		(23,728)
Net loss attributable to common stockholders - basic and diluted	$	(7,449)	$	(25,664)
Denominator:
Weighted-average number of stock used in computing net loss per stock attributable to common stockholders	124,245,358		16,547,808
Net loss per stock attributable to common stockholders – basic and diluted	$	(0.06)	$	(1.55)

Net loss per share calculations and potentially dilutive security amounts for all periods prior to the Transaction have been retrospectively adjusted to the equivalent number of shares outstanding immediately after the Transaction to effect the reverse recapitalization.

The Company’s potentially dilutive securities have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share attributable to common stockholders. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same.

The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:



	Three months ended March 31,
	2022	2021
	(Unaudited)	(Unaudited)
Preferred stock	—	73,690,340
RSU outstanding	7,264,914	—
Options outstanding	10,706,016	12,306,372
Warrants outstanding	10,222,500	680,271